Group 1 - The core viewpoint of the news highlights the significant stock performance of Health Road (02587.HK), which has seen a cumulative increase of 74.92% over the past month and 297.17% year-to-date, outperforming the Hang Seng Index by 18.61% [2] - As of December 31, 2024, Health Road reported total revenue of 1.201 billion yuan, a year-on-year decrease of 3.51%, while the net profit attributable to shareholders was -268 million yuan, an increase of 13.42% [2] - The gross profit margin for Health Road stands at 30.47%, with a debt-to-asset ratio of 59.82% [2] Group 2 - Currently, there are no institutional investment ratings for Health Road [3] - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -21.27 times, with a median of 0.3 times. Health Road's P/E ratio is -157.29 times, ranking 54th in the industry [3] - Health Road operates a digital health service platform in China and is the fourth largest digital health service platform based on registered personal users as of December 31, 2023, and the fifth largest based on revenue for 2023 [3]
健康之路（02587.HK）6月9日收盘上涨15.21%，成交9556.87万港元